CD8A and cancer: As many of the Py230 primary tumours in our immune competent mouse model underwent spontaneous regression or failed to develop at all after cancer cell inoculation, the immune effector populations of CD4+ and CD8+ T cells from the spleen were examined using flow cytometry (Figure 4A).